Nautilus Biotechnology, Inc. (NASDAQ:NAUT)
| Market Cap | 142.53M+58.4% |
| Revenue (ttm) | 190.00K |
| Net Income | -56.52M+14.0% |
| EPS | -0.45+13.5% |
| Shares Out | 127.26M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 3,854,238 |
| Open | 0.94 |
| Previous Close | 0.93 |
| Day's Range | 0.93 - 1.14 |
| 52-Week Range | 0.68 - 4.31 |
| Beta | 0.87 |
| Analysts | Buy |
| Price Target | 2.50(+123.21%) |
| Earnings Date | Oct 27, 2026 |
About NAUT
Nautilus Biotechnology, Inc., a development stage life sciences company, engages in creating a platform technology for quantifying and unlocking the complexity of the proteome in the United States. The company develops Nautilus Voyager Platform, which includes an end-to-end solution comprising instruments, reagents, consumables, and software analysis. It also provides nautilus voyager instrument, a high-resolution optical imaging system with integrated fluidics and liquid handling sub-system to deposit protein libraries onto a flow cell and to process labeled multi-affinity reagent binding and imaging cycles rapidly to decode and quantify the proteins present in biological samples. In addition, the company offers single-molecule library preparation kits, flow cells, affinity reagents, and instrument run buffers to perform multi-cycle analysis runs. It has a research collaboration agreement Genentech, Buck Institute, Allen Institute, Cornell University and the Qatar Foundation, and Michael J. Fox Foundation. Nautilus Biotechnology, Inc. was founded in 2016 and is headquartered in Seattle, Washington.
What Are Insiders Doing?
View the trades behind this meter — each links to its SEC Form 4 →
Open-market Form 4 purchases (code P) vs sales (code S) on file for this company. Grants, option exercises and tax withholdings are excluded. Informational only.
$NAUT stock is featured in our Insider Trades datasets.
→ All Stock ListsRecently reported changes in NAUT holdings by institutional investors
Latest 0 13F filings · Source: SEC EDGAR
View all institutional owners →Insider Trading
Quarterly net insider trading by NAUT's directors and management
Source: SEC EDGAR (Form 4)
Corporate Lobbying
NAUT Estimated quarterly lobbying spending
Source: U.S. Senate LDA
U.S. Patents
New NAUT patent grants
Source: USPTO Open Data Portal
Government Contracts
Estimated quarterly amount awarded to NAUT from public contracts
Source: USAspending.gov
Top ETF Holders
ETFs with the largest estimated holdings in NAUT
| ETF | Est. Holding Size |
|---|---|
| VTIVanguard Morningstar Total Stock Market ETF | $1.89M |
| IWMiShares Russell 2000 ETF | $971.15K |
| VXFVanguard Extended Market ETF | $530.77K |
| IWNiShares Russell 2000 Value ETF | $352.99K |
| VTWOVanguard Russell 2000 ETF | $274.96K |
| IWCiShares Micro-Cap ETF | $153.14K |
Estimated from each fund’s disclosed top holdings × AUM
NAUT Insider Score
Our composite score: insider buying, sector, volume, tone & dilution
Bull Case vs Bear Case
AI-generated from NAUT’s recent data — informational, not investment advice